RIDGEFIELD, Conn., April 8, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa ® (dabigatran ...
Dallas, Nov 18 (Reuters) - An experimental antidote to the widely used blood clot preventer Pradaxa worked immediately and completely in an early-stage trial among healthy volunteers, raising hopes ...
As expected, the European Medicines Agency (EMA) has extended the indications for the oral anticoagulant dabigatran (Pradaxa, Boehringer Ingelheim) to include treatment of deep vein thrombosis (DVT) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback